Immunomedics logo

Immunomedics

103 employees · est. 1982 · United States

VS
Tubulis GmbH logo

Tubulis GmbH

Reimagining ADCs.

119 employees · est. 2019 · Germany

Immunomedics is the older company (1982 vs 2019).

Side-by-Side Comparison

Immunomedics Tubulis GmbH
Founded
1982 older 2019
Headquarters
United States Germany
Employees
103 119
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Post Ipo Equity Acquired
Total Funding
$802.00M $3.66B
Funding Rounds
6 11
Services
Not tracked yet ADC Development, Clinical Research, Biophysical Property Analysis
Target Customers
Not tracked yet Pharmaceutical Companies, Medical Researchers, Oncologists, Cancer Patients
Taxonomy
Immunomedics, Antibody-drug Conjugate, Cancer Treatment, Innovative Technology, Biopharmaceutical, Medical Innovation Antibody Drug Conjugates, Targeted Therapy, Drug Development, Chemotherapy Alternatives, Cancer Treatment, Protein-Drug Conjugates, Disease-Specific Biology, Pharmaceuticals, Chronic Disorder Treatment, Innovative Technology, Oncology
Website
immunomedics.com tubulis.com
Immunomedics logo

About Immunomedics

Immunomedics is a leader in next-generation antibody-drug conjugate (ADC) technology, committed to help transform the lives of people with hard-to-treat cancers. Founded in 1982, the company operates in the Biopharma, Biotechnology, Health Care, and Health and Wellness industries with headquarters i...

Tubulis GmbH logo

About Tubulis GmbH

Tubulis GmbH, with its slogan "Reimagining ADCs.", represents a significant stride in the biotechnology space. Founded in 2019, the company quickly positioned itself at the intersection of Biotechnology, Health Care, Health and Wellness, Life Sciences, and Pharmaceutical sectors. Its headquarter is...

We will tell you when either one moves

BounceWatch watches Immunomedics and Tubulis GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Immunomedics and Tubulis GmbH — by email.

Frequently Asked Questions

Immunomedics. Tubulis GmbH — Reimagining ADCs.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Immunomedics has raised $802.00M while Tubulis GmbH has raised $3.66B.
Immunomedics and Tubulis GmbH operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Immunomedics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Immunomedics on 12 Sep 2024, and Tubulis GmbH on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy